ProZyme is now part of Agilent Technologies, Inc. ProZyme is dedicated to advancing glycobiology research and improving bioph ... armaceutical analysis for optimal design and quality manufacturing of life saving therapies. The company supplies value-added kits, enzymes, standards and a complete CE system for biotherapeutic protein characterization and glycobiology research. ProZyme’s focus on R&D and innovation supports an agile product development program and a strong IP portfolio. read more